Ryuta Yamazaki Selected Research

YHO-13351

4/2013	ABCG2 inhibitor YHO-13351 sensitizes cancer stem/initiating-like side population cells to irinotecan.
7/2011	Novel acrylonitrile derivatives, YHO-13177 and YHO-13351, reverse BCRP/ABCG2-mediated drug resistance in vitro and in vivo.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ryuta Yamazaki Research Topics

Disease

6	Neoplasms (Cancer) 01/2021 - 12/2010
3	Carcinoma (Carcinomatosis) 01/2021 - 10/2002
3	Rheumatoid Arthritis 12/2002 - 07/2002
2	Hematologic Neoplasms (Hematological Malignancy) 01/2021 - 01/2017
2	Breast Neoplasms (Breast Cancer) 04/2013 - 07/2011
2	Colonic Neoplasms (Colon Cancer) 07/2011 - 11/2002
2	Inflammation (Inflammations) 01/2008 - 02/2004
1	Pancreatic Neoplasms (Pancreatic Cancer) 07/2011
1	Leukemia 07/2011
1	Leukemia P388 07/2011
1	Lung Neoplasms (Lung Cancer) 07/2011
1	Hyperplasia 01/2008
1	Alzheimer Disease (Alzheimer's Disease) 08/2005
1	Stomach Neoplasms (Stomach Cancer) 08/2005
1	Testicular Neoplasms (Testicular Cancer) 10/2002

Drug/Important Bio-Agent (IBA)

5	Proteins (Proteins, Gene)FDA Link 05/2017 - 08/2005
3	Irinotecan (Camptosar)FDA LinkGeneric 04/2013 - 10/2002
2	proto-oncogene proteins pimIBA 01/2021 - 01/2017
2	Transcription Factors (Transcription Factor)IBA 05/2017 - 12/2010
2	YHO-13351IBA 04/2013 - 07/2011
2	ProdrugsIBA 07/2011 - 10/2002
2	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 01/2008 - 11/2002
2	Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA 01/2008 - 11/2002
2	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 01/2008 - 07/2002
1	ThiazolidinedionesIBA 01/2021
1	Phosphotransferases (Kinase)IBA 01/2021
1	methanesulfonic acid (methanesulfonate)IBA 01/2021
1	Serine (L-Serine)FDA Link 01/2017
1	Antineoplastic Agents (Antineoplastics)IBA 01/2017
1	Threonine (L-Threonine)FDA Link 01/2017
1	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 07/2011
1	Paclitaxel (Taxol)FDA LinkGeneric 07/2011
1	Topotecan (Hycamtin)FDA LinkGeneric 07/2011
1	Doxorubicin (Adriamycin)FDA LinkGeneric 07/2011
1	YHO-13177IBA 07/2011
1	Mitoxantrone (Novantrone)FDA LinkGeneric 07/2011
1	Pharmaceutical PreparationsIBA 12/2010
1	Celecoxib (Celebrex)FDA Link 01/2008
1	Presenilin-2IBA 08/2005
1	CalciumIBA 08/2005
1	Carrier Proteins (Binding Protein)IBA 08/2005
1	Cycloheximide (Cicloheximide)IBA 08/2005
1	Fluorouracil (Carac)FDA LinkGeneric 08/2005
1	InterferonsIBA 08/2005
1	IntegrinsIBA 08/2005
1	triptolideIBA 02/2004
1	Sodium Salicylate (Salicylate, Sodium)IBA 12/2002
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 12/2002
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 12/2002
1	Anti-Inflammatory Agents (Anti-Inflammatories)IBA 12/2002
1	Etoposide (VP 16)FDA LinkGeneric 10/2002
1	Cisplatin (Platino)FDA LinkGeneric 10/2002
1	BromidesIBA 10/2002
1	PPAR gammaIBA 07/2002

Therapy/Procedure

2	Drug Therapy (Chemotherapy) 04/2013 - 07/2011
1	Therapeutics 05/2017